The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2025. From 1st April, the Single Activity Fee (SAF) will increase by 19p to £1.46 per item. For more information see CPCF arrangements for 2024/25 and [...]
The post Drug Tariff Watch – April 2025 appeared first on Community Pharmacy England.
National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials National Patient Safety Alert Reference Number: NatPSA/2025/001/DHSC Date issued: 17 March 2025 Explanation of identified safety issue Promixin® (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) are being discontinued from early May 2025, with stocks anticipated [...]
The post National Patient Safety Alert: Discontinuation of Promixin® (colistimethate) 1-million unit powder for nebuliser solution unit dose vials appeared first on Community Pharmacy England.
The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]
The post Drug Tariff Watch – March 2025 appeared first on Community Pharmacy England.
Tax credit payments made by HM Revenue & Customs (HMRC) are ending on Saturday 5 April 2025. After this date, people who hold a tax credit exemption certificate will no longer receive automatic entitlement to free NHS prescriptions under the ‘Tax Credit exemption certificate’ category as it will no longer be a valid prescription charge [...]
The post Tax credit exemptions no longer valid from 6 April 2025 appeared first on Community Pharmacy England.
MHRA Class 4 Medicines Notification: Lansoprazole Gastro-resistant Hard Capsules 15mg (Teva UK Limited) Drug alert number: EL(25)A/06 Date issued: 11 February 2025 Teva UK Limited is reporting a minor typographical error on the carton for Lansoprazole Gastro-Resistant Hard Capsules 15mg. There are two instances where the dosage form is stated as “tablets” where it should state [...]
The post MHRA Class 4 Medicines Notification: Lansoprazole Gastro-resistant Hard Capsules 15mg (Teva UK Limited) appeared first on Community Pharmacy England.
Recent Comments